TACT Trial Results to be presented by Tony Lamas, M.D. at ACAM Fall 2012 Conference
The American College for Advancement in Medicine (ACAM) welcomes Tony Lamas, M.D. to ACAM's Fall 2012 Conference and Tradeshow in Las Vegas to present the results from the Trial to Assess Chelation Therapy (TACT).
TACT is a multi-center international collaborative study sponsored by the National Center for Complementary and Alternative Medicine (NCCAM) and was initiated in September 2003 by lead investigator, Tony Lamas, M.D. to determine the safety and effectiveness of EDTA chelation therapy in individuals with coronary artery disease.
“ACAM is thrilled that Dr. Lamas selected our conference as a platform to discuss the research obtained from the TACT Trial,” said Megan Marburger, Executive Director for ACAM. “Our organization prides itself in educating and supporting the brightest minds of the industry and feel honored that our guests will be able to better understand the findings of the TACT trial and its impact on the integrative community directly from the study chair,” she added.
ACAM's Fall Conference and Tradeshow takes place Nov. 14 - 18, 2012 at Planet Hollywood Resort & Casino in Las Vegas. Dr. Lamas will be speaking at lunch on Friday, Nov. 16.
For details on the event please visit: www.acamvegas.com.
About ACAM: The American College for Advancement in Medicine (ACAM) is a not-for-profit organization dedicated to educating physicians and other health care professionals on the safe and effective application of integrative medicine. ACAM's healthcare model focuses on prevention of illness and a strive for total wellness. ACAM is the voice of integrative medicine; our goals are to improve physician skills, knowledge and diagnostic procedures as they relate to integrative medicine; to support integrative medicine research; and to provide education on current standard of care as well as additional approaches to patient care.
American College for Advancement in Medicine
Megan Marburger, 949-309-3520